The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Andreas Schneeweiss

Department of Gynecology and Obstetrics

University of Heidelberg




Name/email consistency: high



  • Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany. 2001 - 2005


  1. Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial. Schneeweiss, A., Schuetz, F., Rudlowski, C., Hahn, M., Lauschner, I., Sinn, H.P., von Fournier, D., Sohn, C. Anticancer. Drugs (2005) [Pubmed]
  2. Induction of remission in a patient with metastatic breast cancer refractory to trastuzumab and chemotherapy following treatment with gefitinib ('Iressa', ZD1839). Schneeweiss, A., Kolay, S., Aulmann, S., Von Minckwitz, G., Torode, J., Koehler, M., Bastert, G. Anticancer. Drugs (2004) [Pubmed]
  3. Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study. Schneeweiss, A., Huober, J., Sinn, H.P., von Fournier, D., Rudlowski, C., Beldermann, F., Krauss, K., Solomayer, E., Hamerla, R., Wallwiener, D., Bastert, G. Eur. J. Cancer (2004) [Pubmed]
  4. Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy. Schneeweiss, A., Diel, I., Hensel, M., Kaul, S., Sinn, H.P., Unnebrink, K., Rudlowski, C., Lauschner, I., Schuetz, F., Egerer, G., Haas, R., Ho, A.D., Bastert, G. Ann. Oncol. (2004) [Pubmed]
  5. Neoadjuvant therapy with gemcitabine in breast cancer. Schneeweiss, A., Bastert, G., Huober, J., Wallwiener, D., Hamerla, R., Lichter, P. Oncology (Williston Park, N.Y.) (2004) [Pubmed]
  6. Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression. Schneeweiss, A., Sinn, H.P., Ehemann, V., Khbeis, T., Neben, K., Krause, U., Ho, A.D., Bastert, G., Krämer, A. Int. J. Cancer (2003) [Pubmed]
  7. Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose. Schneeweiss, A., Hensel, M., Sinn, P., Khbeis, T., Haas, R., Bastert, G., Ho, A.D. Ann. Oncol. (2002) [Pubmed]
  8. Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer. Schneeweiss, A., Hensel, M., Goerner, R., Khbeis, T., Hohaus, S., Egerer, G., Solomayer, E., Haas, R., Grischke, E.M., Bastert, G., Ho, A.D. Stem. Cells (2001) [Pubmed]
WikiGenes - Universities